Avoiding Systemic Heparinization During Hemodialysis: How the Dialysis Setup Might Help
Research article published in Seminars in nephrology (2024)
Abstract
Heparin is the most widely used anticoagulant for maintaining patency of the extracorporeal blood circuit during intermittent hemodialysis. Inadvertently, this leads to systemic heparinization of the patient. Repeated intermittent heparinization during hemodialysis has been associated with increased bleeding risks and metabolic and immunologic effects. Alternative strategies for minimizing systemic anticoagulation encompass dilution methods, regional citrate anticoagulation, priming of the extracorporeal circuit, and modifications to dialyzer membranes and dialysate composition. The effectiveness of these alternatives in maintaining patency of the extracorporeal circuit varies substantially. Although most studies have focused on particular changes in the hemodialysis setup, several combined interventions for adapting the hemodialysis setup are now being studied. This narrative review aims to present an overview of the current landscape of hemodialysis setup strategies aimed at limiting or avoiding systemic anticoagulation during treatment. Additionally, this review intends to shed light on the underlying pathophysiological mechanisms that contribute to variations observed in reported outcomes.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Summary
Peer-reviewed research on safety and infection-control considerations relevant to leech therapy and anticoagulation. Indexed in PubMed and verified against the NCBI record.
Why This Matters for Hirudotherapy
This narrative review surveys strategies for keeping the extracorporeal hemodialysis circuit patent while limiting systemic heparin exposure -- including dilution methods, regional citrate anticoagulation, circuit priming, and dialyzer-membrane and dialysate modifications -- noting that repeated heparinization carries bleeding, metabolic, and immunologic risks and that the effectiveness of alternatives varies. For ASH it is general anticoagulation-safety context; the recurring clinical theme of minimizing systemic anticoagulation is conceptually adjacent to why local leech application is sometimes preferred over systemic agents, but the review is about dialysis engineering, not leeches. Caveat: as a narrative review of hemodialysis circuit management with no medicinal-leech content, it informs background thinking on local-versus-systemic anticoagulation only and provides no direct hirudotherapy evidence.
Citation
Avoiding Systemic Heparinization During Hemodialysis: How the Dialysis Setup Might Help.
Janssens et al. · Seminars in nephrology, 2024
Added to ASH library: May 28, 2026 · Site last updated: June 18, 2026